US5874424A
(en)
*
|
1995-12-20 |
1999-02-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6204261B1
(en)
*
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
US5846981A
(en)
*
|
1993-05-28 |
1998-12-08 |
Gpi Nil Holdings Inc. |
Inhibitors of rotamase enzyme activity
|
US5798355A
(en)
*
|
1995-06-07 |
1998-08-25 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity
|
US6420522B1
(en)
*
|
1995-06-05 |
2002-07-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
US6699869B1
(en)
|
1995-03-24 |
2004-03-02 |
Myriad Genetics Inc. |
β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
|
US6245764B1
(en)
|
1995-03-24 |
2001-06-12 |
Molecumetics Ltd. |
β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
|
US6020331A
(en)
|
1995-03-24 |
2000-02-01 |
Molecumetics, Ltd. |
β-sheet mimetics and use thereof as protease inhibitors
|
CA2215211A1
(fr)
*
|
1995-03-31 |
1996-10-03 |
Takeda Chemical Industries, Ltd. |
Inhibiteur de la protease de cysteine
|
US5859031A
(en)
*
|
1995-06-07 |
1999-01-12 |
Gpi Nil Holdings, Inc. |
Small molecule inhibitors of rotamase enzyme activity
|
US5696135A
(en)
|
1995-06-07 |
1997-12-09 |
Gpi Nil Holdings, Inc. |
Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
|
US5744451A
(en)
*
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
US5801197A
(en)
*
|
1995-10-31 |
1998-09-01 |
Gpi Nil Holdings, Inc. |
Rotamase enzyme activity inhibitors
|
US5843904A
(en)
*
|
1995-12-20 |
1998-12-01 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1βconverting enzyme
|
US5834457A
(en)
*
|
1996-01-26 |
1998-11-10 |
The Regents Of The University Of California |
Method of modulating radical formation by mutant cuznsod enzymes
|
ES2262184T3
(es)
*
|
1996-08-05 |
2006-11-16 |
Myriad Genetics, Inc. |
Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.
|
US6117896A
(en)
|
1997-02-10 |
2000-09-12 |
Molecumetics Ltd. |
Methods for regulating transcription factors
|
EP1661566A3
(fr)
*
|
1996-08-05 |
2008-04-16 |
Myriad Genetics, Inc. |
Utilisation de mimétiques de feuillets beta comme inhibiteurs de protéase et de kinase ou comme inhibiteurs de facteurs de transcription
|
US5869519A
(en)
*
|
1996-12-16 |
1999-02-09 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5801187A
(en)
|
1996-09-25 |
1998-09-01 |
Gpi-Nil Holdings, Inc. |
Heterocyclic esters and amides
|
US6218424B1
(en)
|
1996-09-25 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Heterocyclic ketone and thioester compounds and uses
|
US5786378A
(en)
*
|
1996-09-25 |
1998-07-28 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters
|
US6194435B1
(en)
|
1996-10-11 |
2001-02-27 |
Cor Therapeutics, Inc. |
Lactams as selective factor Xa inhibitors
|
US6316415B1
(en)
|
1996-10-11 |
2001-11-13 |
Basf Aktiengesellschaft |
Sulfonamide interleukin-1β converting enzyme inhibitors
|
AU742746B2
(en)
*
|
1996-10-11 |
2002-01-10 |
Abbott Gmbh & Co. Kg |
Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors
|
US6063794A
(en)
|
1996-10-11 |
2000-05-16 |
Cor Therapeutics Inc. |
Selective factor Xa inhibitors
|
US5919790A
(en)
*
|
1996-10-11 |
1999-07-06 |
Warner-Lambert Company |
Hydroxamate inhibitors of interleukin-1β converting enzyme
|
US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
CA2268391A1
(fr)
*
|
1996-10-18 |
1998-04-30 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de serines proteases, notamment de ns3 protease du virus de l'hepatite c
|
SI0932617T1
(en)
*
|
1996-10-18 |
2002-06-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
EP0940400A4
(fr)
*
|
1996-10-25 |
2002-10-02 |
Mitsubishi Pharma Corp |
Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales
|
WO1998024805A1
(fr)
*
|
1996-12-06 |
1998-06-11 |
Vertex Pharmaceuticals Incorporated |
INHIBITEURS DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE-1$g(b)
|
DE69736984T2
(de)
|
1996-12-06 |
2007-09-13 |
Vertex Pharmaceuticals Inc., Cambridge |
Inhibitoren des interleukin-1-beta konvertierenden enzyms
|
EP1466921A1
(fr)
*
|
1996-12-06 |
2004-10-13 |
Vertex Pharmaceuticals Incorporated |
inhibiteurs de l'enzyme de conversion de l'interleukine-1-beta
|
US6184244B1
(en)
|
1996-12-16 |
2001-02-06 |
Idun Pharmaceuticals, Inc. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5877197A
(en)
*
|
1996-12-16 |
1999-03-02 |
Karanewsky; Donald S. |
C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
|
US5846979A
(en)
|
1997-02-28 |
1998-12-08 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic esters, amides, thioesters, and ketones
|
US6054487A
(en)
*
|
1997-03-18 |
2000-04-25 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
WO1998046626A1
(fr)
|
1997-04-14 |
1998-10-22 |
Cor Therapeutics, Inc. |
INHIBITEURS SELECTIFS DU FACTEUR Xa
|
JP2001521524A
(ja)
*
|
1997-04-14 |
2001-11-06 |
シーオーアール セラピューティクス インコーポレイテッド |
選択的Xa因子阻害剤
|
CA2285659A1
(fr)
|
1997-04-14 |
1998-10-22 |
Cor Therapeutics, Inc. |
Inhibiteurs selectifs du facteur xa
|
HUP9700816A3
(en)
*
|
1997-04-28 |
1999-06-28 |
Gyogyszerkutato Intezet |
3(r)-3-amino-4-carboxy-butiraldehyde derivatives inhibiting release of interleukin-1-beta
|
FR2766188B1
(fr)
*
|
1997-07-15 |
2000-02-11 |
Hoechst Marion Roussel Inc |
Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes
|
US6228854B1
(en)
|
1997-08-11 |
2001-05-08 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6218382B1
(en)
|
1997-08-11 |
2001-04-17 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
US6333321B1
(en)
|
1997-08-11 |
2001-12-25 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
ES2221227T3
(es)
*
|
1997-11-24 |
2004-12-16 |
MERCK & CO., INC. |
Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
|
JP4524039B2
(ja)
*
|
1997-12-18 |
2010-08-11 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
Srcファミリーsh2ドメインインヒビターとしてのピリドン
|
WO1999046248A1
(fr)
|
1998-03-09 |
1999-09-16 |
Vertex Pharmaceuticals Incorporated |
DERIVES DE LA 1,2-DIAZEPANE INHIBITEURS DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE-1$g(b)
|
AP2000001919A0
(en)
|
1998-03-19 |
2000-09-30 |
Vertex Pharma |
Inhibitors of caspases.
|
GB9809664D0
(en)
*
|
1998-05-06 |
1998-07-01 |
Hoffmann La Roche |
a-Ketoamide derivatives
|
US6384056B1
(en)
|
1998-08-14 |
2002-05-07 |
Gpi Nil Holdings, Inc. |
Heterocyclic thioesters or ketones for vision and memory disorders
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
US6395758B1
(en)
|
1998-08-14 |
2002-05-28 |
Gpi Nil Holdings, Inc. |
Small molecule carbamates or ureas for vision and memory disorders
|
US6506788B1
(en)
|
1998-08-14 |
2003-01-14 |
Gpi Nil Holdings, Inc. |
N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
|
US6333340B1
(en)
|
1998-08-14 |
2001-12-25 |
Gpi Nil Holdings, Inc. |
Small molecule sulfonamides for vision and memory disorders
|
US6335348B1
(en)
|
1998-08-14 |
2002-01-01 |
Gpi Nil Holdings, Inc. |
Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
|
US6399648B1
(en)
|
1998-08-14 |
2002-06-04 |
Gpi Nil Holdings, Inc. |
N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
|
US6339101B1
(en)
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
US6218423B1
(en)
|
1998-08-14 |
2001-04-17 |
Gpi Nil Holdings, Inc. |
Pyrrolidine derivatives for vision and memory disorders
|
US7338976B1
(en)
|
1998-08-14 |
2008-03-04 |
Gpi Nil Holdings, Inc. |
Heterocyclic esters or amides for vision and memory disorders
|
US6337340B1
(en)
|
1998-08-14 |
2002-01-08 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
|
US6177565B1
(en)
*
|
1998-08-19 |
2001-01-23 |
Vertex Pharmaceuticals Inc. |
Process for synthesizing piperazic acid
|
US6559304B1
(en)
|
1998-08-19 |
2003-05-06 |
Vertex Pharmaceuticals Incorporated |
Method for synthesizing caspase inhibitors
|
US6201118B1
(en)
|
1998-08-19 |
2001-03-13 |
Vertex Pharmaceuticals Inc. |
Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor
|
US6462072B1
(en)
|
1998-09-21 |
2002-10-08 |
Gpi Nil Holdings, Inc. |
Cyclic ester or amide derivatives
|
JP2003524603A
(ja)
*
|
1998-10-06 |
2003-08-19 |
スミスクライン・ビーチャム・コーポレイション |
カスパーゼおよびアポトーシス
|
JP2002531464A
(ja)
|
1998-12-02 |
2002-09-24 |
メルク フロスト カナダ アンド カンパニー |
カスパーゼ−3阻害薬としてのγ−ケト酸テトラペプチド類
|
WO2000051998A1
(fr)
|
1999-03-02 |
2000-09-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Composes utiles en tant qu'inhibiteurs reversibles de la cathepsine s
|
TW200404789A
(en)
*
|
1999-03-15 |
2004-04-01 |
Axys Pharm Inc |
Novel compounds and compositions as protease inhibitors
|
US6724942B1
(en)
|
1999-05-24 |
2004-04-20 |
Fuji Photo Film Co., Ltd. |
Image processing method and system
|
EP1202976B1
(fr)
*
|
1999-07-19 |
2006-11-02 |
Merck Frosst Canada Ltd. |
Pyrazinones, compositions contenant ces composes
|
US6420364B1
(en)
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
US6417189B1
(en)
|
1999-11-12 |
2002-07-09 |
Gpi Nil Holdings, Inc. |
AZA compounds, pharmaceutical compositions and methods of use
|
US7253169B2
(en)
|
1999-11-12 |
2007-08-07 |
Gliamed, Inc. |
Aza compounds, pharmaceutical compositions and methods of use
|
US6358928B1
(en)
|
1999-11-22 |
2002-03-19 |
Enzyme Systems Products |
Peptidyl sulfonyl imidazolides as selective inhibitors of serine proteases
|
EP1289966A1
(fr)
|
2000-04-11 |
2003-03-12 |
Bristol-Myers Squibb Pharma Company |
LACTAMES SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE PRODUCTION DE PROTEINE A$g(b)
|
EP1282435A2
(fr)
*
|
2000-05-12 |
2003-02-12 |
Immunex Corporation |
Inhibiteurs d'interleukine 1 dans le traitement de maladies
|
PE20011350A1
(es)
|
2000-05-19 |
2002-01-15 |
Vertex Pharma |
PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
|
CN1386118A
(zh)
|
2000-06-01 |
2002-12-18 |
布里斯托尔-迈尔斯斯奎布药品公司 |
作为Aβ蛋白产生抑制剂的被环状琥珀酸酯取代的内酰胺类化合物
|
EP1289993B9
(fr)
|
2000-06-07 |
2008-08-20 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de caspase et utilisations de ces inhibiteurs
|
SV2003000617A
(es)
*
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
NZ526420A
(en)
*
|
2000-11-21 |
2005-08-26 |
Vertex Pharma |
Imidazole and benzimidazole caspase inhibitors and uses thereof
|
AU2002230763A1
(en)
*
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
US6653295B2
(en)
|
2000-12-13 |
2003-11-25 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus NS3 protease
|
AUPR215700A0
(en)
*
|
2000-12-19 |
2001-01-25 |
Fujisawa Pharmaceutical Co., Ltd. |
Carboxylic acid compound having cyclopropane ring
|
US20050192228A1
(en)
*
|
2001-02-05 |
2005-09-01 |
Jean Rapin |
Tripeptide derivatives for the treatment of neurodegenerative diseases
|
DE10105038B4
(de)
*
|
2001-02-05 |
2005-07-07 |
Neurotell Ag |
Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
|
DE10105041A1
(de)
*
|
2001-02-05 |
2002-08-14 |
Tell Pharm Ag Hergiswil |
Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
|
DE10105040A1
(de)
*
|
2001-02-05 |
2002-08-14 |
Tell Pharm Ag Hergiswil |
Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
|
DE10105039A1
(de)
*
|
2001-02-05 |
2002-08-08 |
Tell Pharm Ag Hergiswil |
Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
|
EP1395560A1
(fr)
*
|
2001-05-23 |
2004-03-10 |
Ucb, S.A. |
Derives d'acide alcanoique 2-oxo-piperidinyl- et 2-oxo-azepanyle destines au traitement de l'epilepsie et d'autres troubles neurologiques
|
GB0129260D0
(en)
*
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
JP2005170790A
(ja)
*
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
N−アルキルスルフォニル置換アミド誘導体
|
AU2003211052A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Vertex Pharmaceuticals Incorporated |
Phospholipids as caspase inhibitor prodrugs
|
CA2476113A1
(fr)
|
2002-02-14 |
2003-08-21 |
Myriad Genetics, Inc. |
Mimetiques de feuillet beta; compositions et methodes connexes
|
KR100852649B1
(ko)
*
|
2002-04-22 |
2008-08-18 |
유니버시티 오브 메릴랜드, 볼티모어 카운티 |
캡시드 단백질의 항바이러스 억제
|
US7001899B2
(en)
*
|
2002-06-10 |
2006-02-21 |
The Procter & Gamble Company |
Interleukin converting enzyme inhibitors
|
US7138395B2
(en)
*
|
2002-06-10 |
2006-11-21 |
The Procter & Gamble Company |
Interleukin-1β converting enzyme inhibitors
|
EP1523483A4
(fr)
|
2002-06-26 |
2006-03-08 |
Bristol Myers Squibb Co |
Pyrazinones amino-bicycliques et pyridinones utilisees comme inhibiteurs de coagulation de la serine protease
|
WO2004002406A2
(fr)
*
|
2002-06-26 |
2004-01-08 |
Bristol-Myers Squibb Company |
Pyrimidinones bicycliques inhibiteurs de la cascade de coagulation
|
CN100503572C
(zh)
|
2002-06-28 |
2009-06-24 |
沃泰克斯药物股份有限公司 |
天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途
|
US7612091B2
(en)
*
|
2002-12-20 |
2009-11-03 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
PE20050159A1
(es)
*
|
2003-05-27 |
2005-04-19 |
Vertex Pharma |
Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
|
MY148123A
(en)
|
2003-09-05 |
2013-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
CA2820541A1
(fr)
*
|
2004-02-27 |
2005-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la caspase et leurs utilisations
|
US7652153B2
(en)
*
|
2004-02-27 |
2010-01-26 |
Vertex Pharmaceuticals Incorporated |
Caspase inhibitors and uses thereof
|
AU2011226946B2
(en)
*
|
2004-02-27 |
2012-05-03 |
Vertex Pharmaceuticals Incoporated |
Caspase Inhibitors and Uses Thereof
|
SG150546A1
(en)
*
|
2004-03-12 |
2009-03-30 |
Vertex Pharma |
Processes and intermediates
|
NZ588448A
(en)
|
2004-05-15 |
2012-01-12 |
Vertex Pharma |
Treating seizures using interleukin-1beta converting enzyme (ICE) inhibitors
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
CA2567080A1
(fr)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Traitement de maladies a l'aide d'inhibiteurs de l'ice
|
CN101098855B
(zh)
*
|
2004-11-24 |
2012-06-06 |
沃泰克斯药物股份有限公司 |
3-[2-(3-酰氨基-2-氧代-2h-吡啶-1-基)-乙酰氨基]-4-氧代-戊酸衍生物及其作为天冬氨酸特异性半胱氨酸蛋白酶抑制剂的用途
|
WO2006126730A1
(fr)
*
|
2005-05-26 |
2006-11-30 |
Ajinomoto Co., Inc. |
Dérivés bicycliques de pyrimidine et procédé de synthèse desdits dérivés
|
CN101268084A
(zh)
|
2005-07-28 |
2008-09-17 |
沃泰克斯药物股份有限公司 |
天冬氨酸特异性半胱氨酸蛋白酶抑制剂前体药物
|
MX2008001528A
(es)
*
|
2005-08-02 |
2008-04-04 |
Vertex Pharma |
Inhibidores de serina proteasas.
|
US7964624B1
(en)
*
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
EP1991229A2
(fr)
|
2006-02-27 |
2008-11-19 |
Vertex Pharmaceuticals Incorporated |
Co-cristaux et compositions pharmaceutiques les comprenant
|
BRPI0709567A2
(pt)
*
|
2006-03-16 |
2011-07-12 |
Vertex Pharma |
inibidores deuterados de protease de hepatite c
|
AU2008219704A1
(en)
*
|
2007-02-27 |
2008-09-04 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
EP2463285A1
(fr)
*
|
2007-02-27 |
2012-06-13 |
Vertex Pharmaceuticals Inc. |
Co-cristaux et compositions pharmaceutiques les comprenant
|
MX2010002407A
(es)
*
|
2007-08-30 |
2010-03-26 |
Vertex Pharma |
Cocristales y composiciones farmaceuticas que los comprenden.
|
TW200920355A
(en)
*
|
2007-09-06 |
2009-05-16 |
Lexicon Pharmaceuticals Inc |
Compositions and methods for treating immunological and inflammatory diseases and disorders
|
ES2700613T3
(es)
*
|
2008-07-16 |
2019-02-18 |
Bitop Ag |
Síntesis de amidinas cíclicas
|
EP2635907A4
(fr)
|
2010-11-05 |
2014-04-16 |
Univ Brandeis |
Alpha-synucléine clivée ice en tant que marqueur biologique
|
HU1000676D0
(en)
|
2010-12-17 |
2011-02-28 |
Pharmahungary 2000 Kft |
Inhibitors of matrix metalloproteinase, pharmaceutical compositions thereof and use of them for preventing and treating diseases where the activation of mmp is involved
|
US9956260B1
(en)
|
2011-07-22 |
2018-05-01 |
The J. David Gladstone Institutes |
Treatment of HIV-1 infection and AIDS
|
ES2779748T3
(es)
*
|
2012-08-23 |
2020-08-19 |
Janssen Biopharma Inc |
Compuestos para el tratamiento de infecciones víricas por paramixovirus
|
TWI770525B
(zh)
|
2014-12-30 |
2022-07-11 |
美商瓦洛健康公司 |
作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
|
MA41291A
(fr)
|
2014-12-30 |
2017-11-07 |
Forma Therapeutics Inc |
Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
|
JP2018504432A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのイソチアゾロピリミジノン、ピラゾロピリミジノン及びピロロピリミジノン
|
JP2018504430A
(ja)
|
2015-02-05 |
2018-02-15 |
フォーマ セラピューティクス,インコーポレイテッド |
ユビキチン特異的プロテアーゼ7阻害物質としてのキナゾリノン及びアザキナゾリノン
|
US9932351B2
(en)
|
2015-02-05 |
2018-04-03 |
Forma Therapeutics, Inc. |
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
KR20230038457A
(ko)
|
2020-06-10 |
2023-03-20 |
알리고스 테라퓨틱스 인코포레이티드 |
코로나바이러스, 피코르나바이러스 및 노로바이러스 감염을 치료하기 위한 항바이러스 화합물
|
IL309732A
(en)
|
2021-07-09 |
2024-02-01 |
Aligos Therapeutics Inc |
Antiviral compounds
|